Home Product Detail
Active Pharmaceutical Ingredients (APIs)
  • Doxorubicin

    • API Product   :   

      Doxorubicin

    • CEP   :   

      ¤

    • WCC   :   

      -

    • Therapeutic Use    :   

      Anticancer

    • Originator   :   

      Tokyo Womens Medical University

    • CAS No.    :   

      23214-92-8

    • Trade Name.   :   

      ADRIAMYCIN

    • Molecular Weight   :   

      543.53 g/ mol

    • Molecular Formula   :   

      C27H29NO11

    Application

    Doxorubicin is used to treat many types of cancer, including cancers of the blood (e.g., leukemia), bone, breast, ovaries, testicles, thyroid, head and neck, bladder, stomach and soft tissues, Hodgkin's disease, lung cancer, non-Hodgkin's lymphoma, Wilm's tumour, and neuroblastomas.

    General Description

    Doxorubicin, sold under the trade names Adriamycin among others, is a chemotherapy medication used to treat cancer.[3] This includes breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia.[3] It is often used together with other chemotherapy agents.[3] Doxorubicin is given by injection into a vein.[3] Common side effects include hair loss, bone marrow suppression, vomiting, rash, and inflammation of the mouth.[3] Other serious side effects may include allergic reactions such as anaphylaxis, heart damage, tissue damage at the site of injection, radiation recall, and treatment-related leukemia.[3] People often experience red discoloration of the urine for a few days.[3] Doxorubicin is in the anthracycline and antitumor antibiotic family of medications.[3] It works in part by interfering with the function of DNA.[4]

    ENQUIRE WITH US
    send
    If You Have Any Query than Call us on +91 (22) 4212 8666